66 related articles for article (PubMed ID: 6599708)
21. The effect of varying sodium intake on blood volume, forearm blood flow and vascular responsiveness to sympathetic stimulation in pre-ascitic cirrhosis.
Wong F; Logan A; Blendis L
Clin Invest Med; 1996 Jun; 19(3):184-94. PubMed ID: 8724822
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.
Natali A; Bonadonna R; Santoro D; Galvan AQ; Baldi S; Frascerra S; Palombo C; Ghione S; Ferrannini E
J Clin Invest; 1994 Oct; 94(4):1570-6. PubMed ID: 7929833
[TBL] [Abstract][Full Text] [Related]
23. Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension.
Albillos A; Cacho G; Barrios C; Alvarez-Mon M; Rossi I; Gómez-Arnau J; Pérez-Páramo M; Calleja JL; Muñoz J; Torres MT; Daza R; Cuervas-Mons V; Escartín P
Hepatology; 1998 Feb; 27(2):332-8. PubMed ID: 9462627
[TBL] [Abstract][Full Text] [Related]
24. Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance.
Rosei EA; Rizzoni D; Castellano M; Porteri E; Zulli R; Muiesan ML; Bettoni G; Salvetti M; Muiesan P; Giulini SM
J Hypertens; 1995 Mar; 13(3):341-7. PubMed ID: 7622856
[TBL] [Abstract][Full Text] [Related]
25. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives.
Egan BM; Stepniakowski K
J Hypertens; 1994 Sep; 12(9):1061-7. PubMed ID: 7852750
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia.
Green D; O'Driscoll G; Rankin JM; Maiorana AJ; Taylor RR
Clin Sci (Lond); 1998 Sep; 95(3):361-7. PubMed ID: 9730857
[TBL] [Abstract][Full Text] [Related]
28. Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man.
Hulthén UL; Bolli P; Bühler FR
Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):62S-66S. PubMed ID: 3896282
[TBL] [Abstract][Full Text] [Related]
29. Verapamil-induced vasodilator response is enhanced in essential hypertension.
Bolli P; Hulthén L; Amann FW; Kiowski W; Bühler FR
Gen Pharmacol; 1983; 14(1):185-8. PubMed ID: 6337915
[TBL] [Abstract][Full Text] [Related]
30. Forearm vascular alpha 1-adrenergic blockade by verapamil.
Abernethy DR; Winterbottom LM
Clin Pharmacol Ther; 1990 Jun; 47(6):755-9. PubMed ID: 2162750
[TBL] [Abstract][Full Text] [Related]
31. Calcium entry blockade and alpha-adrenergic vascular reactivity in human beings: differences between nicardipine and verapamil.
Pedrinelli R; Taddei S; Salvetti A
Clin Pharmacol Ther; 1989 Mar; 45(3):285-90. PubMed ID: 2537698
[TBL] [Abstract][Full Text] [Related]
32. Attenuated vasodilator responses to Mg2+ in young patients with borderline hypertension.
Fujita T; Ito Y; Ando K; Noda H; Ogata E
Circulation; 1990 Aug; 82(2):384-93. PubMed ID: 2372889
[TBL] [Abstract][Full Text] [Related]
33. Effects of black race on forearm resistance vessel function.
Kahn DF; Duffy SJ; Tomasian D; Holbrook M; Rescorl L; Russell J; Gokce N; Loscalzo J; Vita JA
Hypertension; 2002 Aug; 40(2):195-201. PubMed ID: 12154113
[TBL] [Abstract][Full Text] [Related]
34. A functional abnormality of the forearm resistance vessels in men with primary hypertension.
Robinson BF; Bayley S; Chiodini P; Dobbs RJ; Phillips RJ; Wilson P
Gen Pharmacol; 1983; 14(1):181. PubMed ID: 6826031
[No Abstract] [Full Text] [Related]
35. Calcium entry blockade and agonist-mediated forearm vasoconstriction in hypertensive patients. Difference between nicardipine and verapamil.
Pedrinelli R; Taddei S; Panarace G; Spessot M; Salvetti A
Eur J Clin Pharmacol; 1991; 40(1):1-5. PubMed ID: 2060535
[TBL] [Abstract][Full Text] [Related]
36. [Calcium metabolism in arterial hypertension. II. Changes in thrombocyte sensitivity to verapamil].
Atakhanov ShE; Tkhostova EB; Iurenev AP; Men'shikov MIu; Mazaev AV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):28-32. PubMed ID: 3401337
[TBL] [Abstract][Full Text] [Related]
37. Calcium influx blockers in the treatment of essential hypertension.
Hulthén UL; Bolli P; Bühler FR
Acta Med Scand Suppl; 1984; 681():101-8. PubMed ID: 6145299
[TBL] [Abstract][Full Text] [Related]
38. Cellular sodium concentration and vasoconstrictor state in hypertension.
Poston L; Gray HH; Crowther A; Dittrich HC; Hilton PJ; Webb-Peploe MM; MacGregor GA
J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S16-20. PubMed ID: 6204135
[TBL] [Abstract][Full Text] [Related]
39. Effects of nifedipine on resistance vessels, arteries and veins in man.
Robinson BF; Dobbs RJ; Kelsey CR
Br J Clin Pharmacol; 1980 Nov; 10(5):433-8. PubMed ID: 7437254
[TBL] [Abstract][Full Text] [Related]
40. Similar vasoconstrictor responses to calcium in normotensive and esssential hypertensive men.
Overbeck HW; Pamnani MB; Derifield RS
Proc Soc Exp Biol Med; 1975 Jun; 149(2):519-25. PubMed ID: 1098055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
